HomeGreater Than Icon
Mutual FundsGreater Than Icon
Compare Mutual FundsGreater Than Icon
Nippon India Pharma Fund - Direct (G) vs Nippon India ELSS Tax Saver Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs Nippon India ELSS Tax Saver Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

13.26%

stock2

Nippon India ELSS Tax Saver Fund - Direct (G)

3.03%

Graph not available
Graph not available

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

5000

8352.16

1.12

558.9293

January 1, 2013

1

Very High Risk

500

15291.63

0.5

137.6469

January 1, 2013

0

22.76 %

26.96 %

13.26 %

26.3 %

24.26 %

3.03 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Ashwani Kumar

B.Sc., MBA - Finance

He has over 10 years of experience in this industry. Among his past learning is a long stretch with Zurich Asset Management Co. India P. Ltd. where he was the Senior Research Analyst, responsible for tracking automotive, metals, and engineering sectors.

Rupesh Patel

Graduate in engineering from Sardar Patel University, Gujarat and holds a masters in business administration from Sardar Patel University, Gujarat.

From June 2013 till date Fund Manager for schemes of Tata Mutual Fund - Reporting to Chief Investment Officer-Equities. Jan 2012 - June 2013 with Tata Asset Management Ltd. as Principal Officer of Tata Asset Management Ltd - PMS. May 2008 - Jan 2012 with Tata Asset Management Ltd as DGM (Investments). Reporting to Head of Research. Aug 2007 - April 2008 with Indiareit Fund Advisors Pvt. Ltd as Asst. Vice President (Investments). Reporting to Director (Investments). Nov 2001 - Aug 2007 with Credit Analysis & Research Ltd. as Deputy General Manager. Reporting to Executive Director.

Sanjay Parekh

B.com,A.C.A

Prior to joining Reliance Mutual Fund he has worked with ICICI Prudential MF, Ask Investments Managers, Prabhudas Lilladher, Sunidhi Consultancy Services, Insight Asset Management and Capital Market Magazine.

Get your FAQs right

When comparing Nippon India Pharma Fund - Direct (G) vs Nippon India ELSS Tax Saver Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both Nippon India Pharma Fund - Direct (G) and Nippon India ELSS Tax Saver Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing Nippon India Pharma Fund - Direct (G) and Nippon India ELSS Tax Saver Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between Nippon India Pharma Fund - Direct (G) and Nippon India ELSS Tax Saver Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare Nippon India Pharma Fund - Direct (G) and Nippon India ELSS Tax Saver Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions